Moroi Rintaro, Shiga Hisashi, Tarasawa Kunio, Yano Kota, Shimoyama Yusuke, Kuroha Masatake, Kakuta Yoichi, Fushimi Kiyohide, Fujimori Kenji, Kinouchi Yoshitaka, Masamune Atsushi
Division of Gastroenterology Tohoku University Hospital Sendai Japan.
Department of Health Administration and Policy Tohoku University Graduate School of Medicine Sendai Japan.
JGH Open. 2021 Apr 4;5(8):842-848. doi: 10.1002/jgh3.12541. eCollection 2021 Aug.
The number of elderly patients with ulcerative colitis (UC) is increasing worldwide. The clinical practice of associated treatment is still unclear. Therefore, we aimed to analyze clinical treatment realities and mortality in elderly and non-elderly patients with UC.
We collected UC patients' data using the diagnosis procedure combination (DPC) database system and divided eligible patients into elderly (≥65 years) and non-elderly (≤64 years) groups. We investigated and compared their therapeutic histories (medical treatments . surgery). Logistic regression analysis was conducted to identify clinical factors affecting surgery and in-hospital death in each group.
The rates of systemic steroid injection, molecular targeting drug usage, and surgery were not different between the two age groups. Meanwhile, the rate of in-hospital death in elderly patients was higher than that in non-elderly patients (2.7% . 0.19%, < 0.0001). Multivariate analysis revealed that lower body mass index, treatment at an academic hospital, smoking history, molecular targeting drug use, and treatment with systemic steroid injection affected the rate of surgery in the elderly group. Multivariate analysis also revealed that male and older age affected the rate of in-hospital death in the elderly group. Similar tendencies were also recognized in the non-elderly group.
The clinical practice of treating elderly patients with UC is overall not different from treating non-elderly patients with UC. Although the form of medical treatment and surgery rate for elderly patients with UC may not be significantly different from non-elderly patients, the rate of in-hospital death for elderly patients is higher.
全球范围内,老年溃疡性结肠炎(UC)患者数量不断增加。相关治疗的临床实践仍不明确。因此,我们旨在分析老年和非老年UC患者的临床治疗现状及死亡率。
我们使用诊断程序组合(DPC)数据库系统收集UC患者的数据,并将符合条件的患者分为老年组(≥65岁)和非老年组(≤64岁)。我们调查并比较了他们的治疗史(药物治疗、手术治疗)。进行逻辑回归分析以确定影响每组手术和院内死亡的临床因素。
两个年龄组之间全身类固醇注射率、分子靶向药物使用率和手术率没有差异。同时,老年患者的院内死亡率高于非老年患者(2.7%对0.19%,P<0.0001)。多变量分析显示,较低的体重指数、在学术医院接受治疗、吸烟史、分子靶向药物使用以及全身类固醇注射治疗影响老年组的手术率。多变量分析还显示,男性和高龄影响老年组的院内死亡率。非老年组也观察到类似趋势。
老年UC患者的临床治疗实践总体上与非老年UC患者无异。虽然老年UC患者的药物治疗形式和手术率可能与非老年患者没有显著差异,但老年患者的院内死亡率更高。